Exercise Training for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether exercise therapy, also known as Exercise Training, can improve heart function, overall health, and quality of life for individuals with pulmonary hypertension caused by heart failure. Participants will either join a supervised exercise program for 10 weeks or continue with their usual medical care while undergoing exercise testing. The trial seeks individuals with stable heart failure for over three months and a heart condition affecting pumping efficiency (LVEF < 40%). As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance treatment options for heart failure.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that your condition and medications have been stable for more than 3 months.
What prior data suggests that exercise training is safe for patients with pulmonary hypertension caused by heart failure?
Research has shown that exercise is generally safe for people with heart failure. In one study, out of more than 300 exercise sessions, only one resulted in a minor issue, specifically a brief fainting spell. Other studies have found that exercise not only improves heart function and increases exercise capacity but also enhances the quality of life for those with heart failure. To date, exercise has been well-received, with very few negative incidents reported.12345
Why are researchers excited about this trial?
Researchers are excited about exercise training for heart failure because it offers a non-pharmaceutical approach that can complement standard medications like ACE inhibitors, beta-blockers, and diuretics. Unlike these drugs, exercise training aims to improve cardiovascular health by enhancing heart function and overall fitness directly through physical activity. This method not only targets symptoms but also empowers patients to actively participate in their own health management, potentially leading to better quality of life and reduced hospitalizations. Plus, it can provide benefits in a relatively short period, as the study involves just 10 weeks of supervised sessions.
What evidence suggests that exercise training might be an effective treatment for heart failure?
Research has shown that exercise can greatly benefit people with heart failure. In this trial, participants in the exercise training arm will undergo supervised exercise sessions. Studies have found that these sessions can improve heart function and increase exercise endurance. As a result, patients can remain active for longer periods. Exercise also eases daily activities, enhancing overall quality of life, and may reduce the likelihood of hospitalization. Overall, exercise offers a promising approach to managing heart failure symptoms effectively.12367
Who Is on the Research Team?
Bryan Taylor, PhD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for heart failure patients with reduced heart function (LVEF < 40%) who've been stable for over 3 months and can exercise on a bike or treadmill. It's not for those in the most severe stage of heart failure, pregnant women, individuals with certain other health issues like severe obesity or uncontrolled diabetes, or conditions that limit exercise.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Exercise Testing
Participants undergo exercise testing to assess baseline cardiopulmonary function
Treatment
Participants are randomized to either 10 weeks of supervised exercise training or continue standard medical care
Follow-up
Participants are monitored for changes in pulmonary and cardiac function after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Florida Heart Research Institute
Collaborator